In vivo and in vitro activity of roxithromycin againstToxoplasma gondii in mice
- 26 Downloads
Roxithromycin protected mice against a lethal infection with the extremely virulent RH strain and the CS6 strain ofToxoplasma gondii. Therapy initiated 2 h after infection with 2×103 or 2×104 RH or C56 tachyzoites protected more than 80% of the mice, compared with 0% of untreated controls (p < 0.001). Paradoxically,Toxoplasma gondii was isolated more frequently (> 80%)in treated mice surviving infection with the less virulent strain (CS6) than those surviving infection with the more virulent RH strain (< 25%). Furthermore, in vitro studies revealed that roxithromycin at dosages up to 250 μg/ml had no effect on the proliferation ofToxoplasma gondii in murine peritoneal macrophage cultures.
KeywordsInternal Medicine Untreated Control Virulent Strain Peritoneal Macrophage Treated Mouse
Unable to display preview. Download preview PDF.
- 3.Eyles, D. E., Coleman, N.: Notes on the treatment of acute experimental toxoplasmosis of the mouse with chlortetracycline and tetracycline. Antibiotics and Chemotherapy 1955, 5: 529–539.Google Scholar
- 7.Mack, D. G., McLeod, R.: New micromethod to study the effect of antimicrobial agents onToxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A. Antimicrobial Agents and Chemotherapy 1984, 26: 31–35.PubMedGoogle Scholar